NEW REPORT: J&J Vaccine Is A Greater Risk for Women, Regarding Brain Vein Clots!

According to various reports, “women are reportedly at a higher risk of cerebral venous sinus thrombosis (CVST) when taking the Johnson & Johnson COVID vaccine.”

Join The True Defender Telegram Chanel Here:

A team led by Aneel Ashrani, MD, MS, of the Mayo Clinic in Rochester, Minnesota, shared the findings of this study in a report released on November 1st.

Based on the study, “though CVST reactions are rare following administered doses of the Johnson & Johnson vaccine, the aforementioned condition developed more frequently in women. Apparently, 29 of the 39 CVST occurrences were linked to a risk factor for venous thromboembolism, such as infection, cancer, or recent oral contraceptive usage. The median age at CVST diagnosis was 41, and 56.4 percent of those diagnosed were women.

“Those at highest risk of CVST after receiving the Johnson & Johnson product in early 2021 were women ages 30 to 39 (26.52 per 100,000 person-years) and women ages 40 to 49 (29.48 per 100,000 person-years) — with women, in general, having a 5.1-fold higher risk after vaccination than they did before the COVID pandemic (13.01 vs 2.53 per 100,000 person-years, P<0.001).” Just to point out the contrast of the results of this scientific study, and the VAERS reports... "VAERS reports from persons who got the Johnson & Johnson vaccination between February 28th and May 7th this year revealed 38 CVST incidents with adequate information or imaging. Reportedly 27 of the cases affected women, with a median age of 45 years." GBS can cause muscle weakness, and in some cases cause paralysis. Would you risk it?!


Ava Garcia

A small town girl, dreaming big, expecting to change the world with presenting the truthful events of the world today. Law degree with a master in criminology, and a devoted journalist for over 7 years, and counting. "The pen is mightier than the sword."

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Back to top button

Adblock Detected

For continue reading on the site please disable the Ad-block